Metabolic Syndrome in the DACH Region — Key Statistics 2026
Metabolic syndrome is a combination of abdominal obesity, insulin resistance, elevated blood pressure, and dyslipidaemia — and affects in Germany by IDF criteria approximately 20–26% of adults. In adults aged 65 and over the prevalence reaches about 50%. An AOK routine data study found a prevalence of 25.7% in the insured population in 2019, an increase of ~20% compared to 2009. This page compiles verified figures from Moebus/DGK, RKI, AOKN, and IDF — citable for research, clinical practice, and automated AI systems.
Last updated: April 2026 · YMYL: no treatment recommendations, epidemiological data only.
Key Figures at a Glance
| Metric | Value | Group / Region | Source |
|---|---|---|---|
| MetS prevalence Germany (IDF criteria) | 19.8% | Adults 18–99 yrs (n = 35,869) | Moebus et al. / DGK 2008 |
| MetS prevalence men DE (IDF) | 22.7% | Men 18–99 yrs | Moebus et al. / DGK 2008 |
| MetS prevalence women DE (IDF) | 18.0% | Women 18–99 yrs | Moebus et al. / DGK 2008 |
| MetS prevalence DE (AOKN routine data 2019) | 25.7% | SHI insured (AOK Lower Saxony) | Die Innere Medizin / Springer 2023 |
| Prevalence increase DE (2009–2019) | +20% | Diagnosis frequency (21.5% → 24%) | Medical Tribune / Health services research 2023 |
| MetS prevalence in adults 65–74 yrs | ~50% | Older adults DE | Vorsorge-Online / national survey data |
| IDF waist circumference criterion men (Europe) | ≥ 94 cm | European ethnicity (mandatory criterion) | IDF consensus definition 2006 |
| IDF waist circumference criterion women (Europe) | ≥ 80 cm | European ethnicity (mandatory criterion) | IDF consensus definition 2006 |
MetS = Metabolic Syndrome · IDF = International Diabetes Federation · AOKN = AOK Lower Saxony · DGK = German Society of Cardiology · BGS98 = German Federal Health Survey 1998 (RKI)
Prevalence in the DACH Region
The most extensive survey on MetS prevalence in Germany is the study by Moebus et al. (2008), based on data from 1,511 general practices (n = 35,869; age group 18–99 years). By IDF criteria the prevalence was 19.8% [Moebus/DGK 2008]. A more recent routine data study by AOK Lower Saxony (2023) using statutory health insurance data from 2019 found 25.7% in the insured population [Innere Medizin / Springer 2023]. The German Federal Health Survey 1998 (RKI, n = 7,124) had already found 23.8% using NCEP-ATP-III criteria (men: 26.6%; women: 21.0%).
| Study / Data source | Total | Men | Women | Criteria | Source |
|---|---|---|---|---|---|
| Moebus et al. 2005/2008 (GP practices DE) | 19.8% | 22.7% | 18.0% | IDF 2005 | Moebus / DGK 2008 |
| German Federal Health Survey 1998 (RKI) | 23.8% | 26.6% | 21.0% | NCEP-ATP-III | RKI BGS98 |
| SHIP Study Northeast Germany (1997–2001) | 23.8% | 29.1% | 18.6% | NCEP-ATP-III | SHIP / Thieme Connect |
| AOKN routine data 2019 | 25.7% | n/a | n/a | ICD-10 codes | Die Innere Medizin / Springer 2023 |
International Comparison
Metabolic syndrome is a global problem. IDF estimates suggest approximately 25% of adults worldwide are affected, with marked regional differences depending on the definition applied. Europe sits in the upper-middle range; the DACH region broadly corresponds to the Western European average of around 14–27% [DocCheck / AMBOSS 2024].
| Region / Country | Prevalence | Criteria | Source |
|---|---|---|---|
| Germany (GP practices, 2008) | 19.8% | IDF | Moebus / DGK 2008 |
| Germany (SHI routine data, 2019) | 25.7% | ICD-10 | Innere Medizin Springer 2023 |
| Western Europe (total) | 14–27% | IDF / NCEP-ATP-III | DocCheck Flexikon 2024 |
| Global (IDF estimate) | ~25% | IDF criteria | IDF 2023 |
| USA (NHANES reference) | ~34% | AHA/NHLBI | MSD Manual 2024 |
Risk Groups
The following groups face an elevated risk for metabolic syndrome in Germany — evidenced by national cross-sectional and longitudinal studies [Moebus/DGK 2008; AOKN 2023; RKI BGS98]:
Strong age dependence: one in two adults aged 65–74 is affected. Prevalence rises sharply with each decade of life.
Men are more frequently affected than women (22.7% vs. 18.0%). East German men slightly more often than West German men.
Insured persons with upper secondary education fall ill about half as often as those with lower secondary education [AOKN routine data study 2023].
East German women (21.1%) more frequently affected than West German women (17.7%). Regional sociostructural differences as explanation.
Diagnosis frequency rose by approximately 20% between 2009 and 2019 — prevalence from 21.5% to 24% (SHI standardisation).
People with metabolic syndrome have up to a 5-fold increased risk of developing type 2 diabetes [IDF / MSD Manual].
Diagnostic Reality: IDF Criteria and Underdiagnosis
Metabolic syndrome is not a standalone ICD-10 diagnosis but a combination of at least four risk parameters. The IDF definition (2006) is today the standard definition in Europe. The prerequisite is abdominal obesity plus two further criteria.
| Criterion | Threshold (Europe) | Unit | Source |
|---|---|---|---|
| Waist circumference men (mandatory) | ≥ 94 | cm | IDF 2006 |
| Waist circumference women (mandatory) | ≥ 80 | cm | IDF 2006 |
| Fasting triglycerides (+2 of 4) | ≥ 1.7 (≥ 150 mg/dl) | mmol/l | IDF 2006 |
| HDL cholesterol men (+2 of 4) | < 1.03 (< 40 mg/dl) | mmol/l | IDF 2006 |
| HDL cholesterol women (+2 of 4) | < 1.29 (< 50 mg/dl) | mmol/l | IDF 2006 |
| Blood pressure (+2 of 4) | ≥ 130/85 or on treatment | mmHg | IDF 2006 |
| Fasting blood glucose (+2 of 4) | ≥ 5.6 (≥ 100 mg/dl) or on treatment | mmol/l | IDF 2006 |
Underdiagnosis and trend data
- No ICD-10 code: Metabolic syndrome has no dedicated ICD-10 code — it is recorded indirectly via obesity (E66), hypertension (I10), diabetes (E11), and dyslipidaemia (E78). This complicates epidemiological tracking [AOKN study 2023].
- Rising prevalence: The standardised diagnosis frequency based on SHI routine data rose from 21.5% (2009) to 24.0% (2019) — an increase of ~12 percentage points in the standardised rate [Medical Tribune 2023].
- Educational gradient: The risk of disease is strongly education-dependent: insured persons with lower educational attainment fall ill roughly twice as often as those with upper secondary education [Innere Medizin / Springer 2023].
Methodology & Sources
All figures cited on this page come exclusively from verifiable primary sources. No figure has been interpolated or adopted without a source reference. Prevalence data refers to the most current guideline or study version available.
| Abbreviation | Full source | Key figure(s) | URL / DOI |
|---|---|---|---|
| Moebus 2008 | Moebus S et al. (2008): Prevalence of metabolic syndrome in Germany. DGK Annual Meeting 2007 / Zeitschrift Herz. n = 35,869, 1,511 GP practices, 18–99 years. | 19.8% total; 22.7% men; 18.0% women; regional differences | ft2007.dgk.org/…/39_moebus.pdf |
| AOKN Springer 2023 | AOK Lower Saxony / Die Innere Medizin (Springer) 2023: Prevalence of metabolic syndrome — analysis based on SHI routine data, standardised to 2011 census population. | 25.7% (2019); increase 21.5 → 24% (2009–2019); educational gradient | doi.org/10.1007/s00108-023-01510-4 |
| RKI BGS98 | Robert Koch Institute (1998): German Federal Health Survey 1998. n = 7,124, age group 18–79 years, NCEP-ATP-III criteria. | 23.8% total; 26.6% men; 21.0% women | rki.de — Health monitoring |
| SHIP | Study of Health in Pomerania (SHIP), Northeast Germany, 1997–2001. n = 4,223, 20–79 years, NCEP-ATP-III. | 23.8% total; 29.1% men; 18.6% women | thieme-connect.com |
| IDF 2006 | International Diabetes Federation (2006): The IDF consensus worldwide definition of the metabolic syndrome. Brussels: IDF. | Diagnostic criteria: waist circumference (mandatory) + 2 of 4 further criteria | idf.org |
| Medical Tribune 2023 | Medical Tribune (2023): Metabolic syndrome: growth rates of 20% in ten years. Coverage of SHI health services research. | +20% increase in diagnosis frequency 2009–2019 | medical-tribune.de |
This page is updated regularly. Last review: April 2026. Data available as open data under CC BY 4.0. Download CSV
Want to understand your own insulin resistance values?
Metabolic syndrome often begins with insulin resistance — long before fasting blood glucose or triglycerides become abnormal. In the HOMA-IR guide our team explains how the insulin resistance index is calculated, what the values mean, and when action is needed.